Israel’s Techsomed Medical Technologies (see here previously) has received US FDA approval for its BioTraceIO groundbreaking ultrasound-based liver ablation software. It helps surgeons to see the real-time status of liver tumors while they use thermal ablation therapy to destroy them.

https://www.prnewswire.com/news-releases/techsomeds-biotrace-solution-achieves-de-novo-clearance-from-fda-as-the-first-ultrasound-based-software-for-tissue-response-prediction-in-liver-tumor-ablation-302028369.html

https://nocamels.com/2024/01/israeli-company-gets-fda-clearance-for-liver-tumor-software/